Brief: Bicycle Therapeutics Announces FDA Fast Track Designation For Bt8009
04/01/2023 12:43
Jan 4 (Reuters) - Bicycle Therapeutics PLC BCYC.O :
* BICYCLE THERAPEUTICS ANNOUNCES FDA FAST TRACK DESIGNATION
GRANTED TO BT8009 FOR THE TREATMENT OF ADULT PATIENTS WITH
PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL
CANCER
Source text for Eikon: ID:nBw3HwQf2a
Further company coverage: BCYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics PLC reports results for the quarter ended September 30 - Earnings Summary
UK's Bicycle Therapeutics Q3 loss narrows as expenses fall
Bicycle Therapeutics PLC expected to post a loss of 43 cents a share - Earnings Preview
UK's Bicycle Therapeutics Q2 net loss narrows on reduced clinical program expenses
Bicycle Therapeutics Q1 revenue drops after partnership terminations